S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Rayaldee Phase 3 Trial Meets Primary Endpoints|
|OPKO Submits IND for Rayaldee™ as Adjunctive Cancer Therapy|
|OPKO Granted Patent from US Patent & Trademark Office for RAYALDEE|
|AMAG Pharmaceuticals Appoints Robert Blood as Vice President of Legal Affairs and Chief Compliance Officer|
|Celebrity Chef to Share Cooking Tips for Restricted Diets At American Association of Kidney Patients Event|
|Rockwell Medical Announces FDA Approves $2.2 Million Application Fee Refund for Triferic(TM) NDA|
|Xenetic Biosciences Announces Ongoing Safety Data From Phase 2 Trial of ErepoXen(R)|
|Rockwell Medical Receives FDA Approval for Calcitriol|
|Mariel Therapeutics Announces Definitive Agreement to Acquire Stryker's BMP-7 Assets for Potential Use in Osteoarthritis and Organ Fibrosis|
|Rockwell Medical Schedules 2nd Quarter 2014 Investor Conference Call|
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.
Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
Click above to view more mutual fund data and stats for 6407 - CKD Corporation.